Weibin Zha Selected Research

Weibin Zha Research Topics

3	Glucose Intolerance 10/2019 - 01/2016
3	Obesity 10/2019 - 10/2014
3	HIV Infections (HIV Infection) 01/2013 - 02/2010
2	Inflammation (Inflammations) 01/2016 - 01/2014
2	Hyperlipidemias (Hyperlipidemia) 02/2015 - 03/2010
2	Atherosclerosis 09/2009 - 07/2009
1	Type 2 Diabetes Mellitus (MODY) 10/2019
1	Infarction (Infarctions) 02/2018
1	Cerebral Infarction 02/2018
1	Insulin Resistance 01/2017
1	Diabetes Mellitus 10/2016
1	Alcoholic Fatty Liver 01/2016
1	Fatty Liver 01/2014
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Neoplasms (Cancer) 01/2013
1	Chronic Disease (Chronic Diseases) 06/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2010
1	Fistula 08/2010
1	Dyslipidemias (Dyslipidemia) 02/2010
1	Pathologic Processes 09/2008
1	Hypertension (High Blood Pressure) 09/2008

5	HIV Protease InhibitorsIBA 01/2013 - 07/2009
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2016 - 01/2014
2	Estrogens (Estrogen)FDA Link 10/2019 - 01/2017
2	Aromatase (CYP19)IBA 10/2019 - 01/2017
2	Paroxetine (Paxil)FDA LinkGeneric 10/2019 - 01/2017
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2019 - 01/2017
2	Epoxide HydrolasesIBA 01/2016 - 01/2014
2	BerberineIBA 02/2015 - 02/2010
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 10/2016
1	AcidsIBA 10/2014
1	CytochromesIBA 10/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013
1	Plant ExtractsIBA 06/2012
1	Imatinib Mesylate (Gleevec)FDA Link 10/2010
1	bcr-abl Fusion ProteinsIBA 10/2010
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 08/2010
1	Taurocholic Acid (Sodium Taurocholate)IBA 08/2010
1	PhosphoenolpyruvateIBA 08/2010
1	SolventsIBA 03/2010
1	CholesterolIBA 09/2009
1	Biomarkers (Surrogate Marker)IBA 09/2008

2	Therapeutics 01/2016 - 01/2014
1	Pedicle Screws 02/2018
1	Reoperation 02/2018
1	Highly Active Antiretroviral Therapy (HAART) 01/2013